News

The latest BÜHLMANN poster about Therapeutic Drug Monitoring at the United European Gastroenterology Week 2021

Quantum Blue® Infliximab and Quantum Blue® Adalimumab offer quantification of infliximab and adalimumab originator drugs, as well as their biosimilars, allowing for identification of patients with suboptimal drug levels as part of their therapeutic drug monitoring.

Read more

Omicron Stealth (BA.2) – Seegene lauches new SARS-COV-2 Variant Assay

We are happy to announce the new Novaplex™ SARS-CoV-2 Variant VII Assay from Seegene, which will become available by the end of December 2021.

Read more

Seegene Notification about the detectability of Omicron variant, B.1.1.529

We received the notification from Seegene, in which they confirmed the detectability of Allplex™ assays with respect to the Omicron variant, B.1.1.529 of SARS-CoV-2, which has emerged in South Africa.

Read more

Successful evaluation of the BÜHLMANN fPELA® turbo test at Synlab in Lucerne

Interview with Dr. Cyril A. Fuhrer about the successful evaluation of the BÜHLMANN fPELA® turbo test at Synlab Suisse SA in Lucerne.

Read more